PURPOSE: This study aimed to examine the changes in the outbreak of acute gastroenteritis, rotavirus gastroenteritis after the introduction of the rotavirus vaccine in Korea. METHODS: The current study investigated the number of inpatients in the pediatric ward of Inje University Sanggye Paik Hospital during the periods of 2005-2006 and 2011-2012. A retrospective analysis was conducted on the medical records of 2,840 patients <5 years of age who were hospitalized at Inje University Sanggye Paik Hospital in these time periods. RESULTS: When we compared 2 separate sets of data from before (2005-2006) and after (2011-2012) vaccine introduction, there were statistically significant decreases in the number of patients who were hospitalized for acute gastroenteritis across all of the groups of patients <5 years of age except those <2 months of age. The number of patients with rotavirus gastroenteritis in all age groups declined except for children <2 months of age and those 2-5 months of age. CONCLUSION: These results show that after the introduction of a rotavirus vaccine in Korea, the incidence of rotavirus gastroenteritis decreased in 6-59-month-old patients hospitalized for acute gastroenteritis.
Child* ; Gastroenteritis* ; Humans ; Incidence ; Inpatients ; Korea ; Medical Records ; Retrospective Studies* ; Rotavirus Vaccines* ; Rotavirus* ; Tertiary Care Centers* ; Vaccination

The aim of the investigation was to study the efficacy and safety of Famotidine (Gaster), a new, potent, histamine H-receptor antagonist. The Famotidine (40 mg p.o.h.s) was administered to 22 patients with 33 peptic ulcers for 4 weeks. Follow up checking was done at 2 week and 4 week by endoscopy and physical examination. All patients were carefully evaluated at regular intervals for adverse drugh reactions by clinical and laboratory examinations. By the end of study, 97% of the ulcers were healed by endoscopically and rapid and complete relief of epigastric pain was observed in all patients. Famotidine treatment was well tolerated and no alterations in laboratory tests were noted. Therfore, Famotidine was proved effective in the treatment of peptic ulcers (especially multiple ulcers) and was well tolerted on the short-term basis.
Endoscopy ; Famotidine* ; Follow-Up Studies ; Histamine ; Humans ; Peptic Ulcer* ; Physical Examination ; Ulcer

No abstract available.
Meningitis*

No abstract available.
Glutathione Transferase* ; Glutathione* ; Schistosoma japonicum* ; Schistosoma*

The authors report an extremely rare case of a massive hyperostotic meningioma en plaque, which had characteristics of unique bony growth. A 34-year-old man presented with a palpable solid mass in the left cranial region that had gradually grown in size with a broad base on the calvarium for 8 years. Radiologically, the area involved by the mass ranged from the sphenoid bone to the frontal, parietal, temporal, and occipital bones. Three-dimensional CT revealed multiple growing spiculate features on the inner and outer cranial surface. Even though the radiologic features resembled fibrous dysplasia, it was histologically found to be a type of meningioma.

Trichorrhexis nodosa(TN) denotes small node-like swelling with a loss of cuticle of the hair shaft through which the hair readily fractures. The basic cause of TN is mechanical or chemical trauma, and a contributing factor is an inherent weakness of the hair shaft. We report a case of localized TN in a 37-year-old male. He had an ovoid hair patch with multiple small white-gray dotted and stubby hairs localized to the right occipital scalp. TN is known to be the commonest of all hair shaft anomalies (Price, 1975). However TN is rarely reported, and there have been only four reports in Korean dermatological literature, to our knowledge, which might be due to underdiagnosis of this disorder. We postulated that diagnostic difficulty lies in the discrepancy between terminology and gross morphological findings.
Adult ; Fibrinogen ; Hair ; Humans ; Male ; Scalp

No abstract available.
Hypertrophy, Left Ventricular* ; Kidney Failure, Chronic*

The purine antimetabolite 6-Mercaptopurine (6-MP) has been in clinical use for over 30 years and is still a widely used agent in the treatment of childhood acute lymphoblastic leukemia. The bioavailibility, clinical efficacy and toxicity of 6-MP administered orally for maintenance therapy of children with acute lymphoblastic leukemia are highly variable in many studies, as well as at differnt times in same patient. there are many factors affecting the bioavailibility of 6-MP. The most notably factor being that concomitantly administered drugs and foods might contribute to a decrease in the bioavailibity of this drug. In our sociocultural environment milk is a major constituent of child's foods. Cow's milk contains a high concentration of xanthine oxidase, which could potentially transform 6-TM into 6-thioxanthine (6-TX) and 6-thiouric acid (6-TUA) which have no more therapeutic effects. In this study, we evaluated the effect of various milk products on the bioavailability of 6-MP. Incubation at 37degrees C for 30 min raw or pasteurized milk resulted in transformation of a large quantity of clinically relevant concentration of 6-MP into 6-TUA. The concomitant adminstration of folic acid and allopurinol has markedly inhibitory effect on the 6-MP destroying activity of milk at clinically relevant concentrations. These observations may help to optimize modalities of administration of 6-MP for the treartment of patients with childhood leukemia.
6-Mercaptopurine* ; Allopurinol ; Biological Availability* ; Child ; Complement Factor B ; Folic Acid ; Humans ; Leukemia ; Milk* ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; Xanthine Oxidase

We report a case of trichorrhexis nodosa in a 27-year-old male. Scanning electron microscopic findings reveals those of typical trichorrhexis nodosa nodal swelling of affected hair showed longitudinal fissures and fractures in the cortex. A paintbrush effect was noted at the site of fracture. Simple avoidance of trauma gave some regrowth of hairs.
Adult ; Hair ; Humans ; Male

BACKGROUND: Myelopathies are classified as intramedullary and extramedullary one on the basis of location of lesion. Though there are some characteristic clinical findings which can differentiate extramedullary from intramedullary lesions, it is not easy to tell extramedullary from intramedullary lesions in complicated cases. We performed this study to figure out the relationships between anatomic location (intramedullary or extramedullary), clinical parameters (motor and sensory symptoms and signs), and electrophysiologic findings in myelopathy. We also investigated the diagnostic value of motor evoked potential (MEP) compared with that of somatosensory evoked potential (SSEP) in myelopathy. The amplitude changes of compound muscle action potential (CMAP) after motor cortex stimulation have a lot of intra-individual and inter-individual variability, so were not used to determine pyramidal tract dysfunction in clinical ground. We analyzed CMAP amplitude changes in myelopathy. METHODS: Fifty-six patients with myelopathy demonstrated in MRI were studied. We defined abnormal CMAP amplitude changes as intra-individual inter-side amplitude ratio more than 50%. RESULTS: Lower MEP showed abnormal findings in 93% of tests and lower SSEP, 37% (p<0.05). The correla-tions between clinical parameters and electrophysiologic findings were higher in lower MEP (71%) than lower SSEP (42%) (p<0.05). CONCLUSIONS: The results of this study suggest that MEP is more useful than SSEP for detecting spinal cord dysfunction but as false positivity of lower MEP was considerable, MEP and SSEP are reciprocal diagnostic method for myelopathy. SSEP and MEP do not have significant diagnostic values in differentiating extramedullary from intramedullary myelopathy. The inter-side CMAP amplitude difference may indicate subclinical spinal cord dysfunction.
Action Potentials ; Evoked Potentials ; Evoked Potentials, Motor* ; Evoked Potentials, Somatosensory ; Humans ; Magnetic Resonance Imaging ; Motor Cortex ; Pyramidal Tracts ; Spinal Cord ; Spinal Cord Diseases*